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Abstract
Background: Real-time measurement of thermal neutrons in the tumor region is essential for proper evaluation of
the absorbed dose in boron neutron capture therapy (BNCT) treatment. The gold wire activation method has been
routinely used to measure the neutron flux distribution in BNCT irradiation, but a real-time measurement using gold
wire is not possible. To overcome this issue, the scintillator with optical fiber (SOF) detector has been developed.
The purpose of this study is to demonstrate the feasibility of the SOF detector as a real-time thermal neutron
monitor in clinical BNCT treatment and also to report issues in the use of SOF detectors in clinical practice and their
solutions.
Material and methods: Clinical measurements using the SOF detector were carried out in 16 BNCT clinical trial
patients from December 2002 until end of 2006 at the Japanese Atomic Energy Agency (JAEA) and Kyoto University
Research Reactor Institute (KURRI).
Results: The SOF detector worked effectively as a real-time thermal neutron monitor. The neutron fluence obtained
by the gold wire activation method was found to differ from that obtained by the SOF detector. The neutron
fluence obtained by the SOF detector was in better agreement with the expected fluence than with gold wire
activation. The estimation error for the SOF detector was small in comparison to the gold wire measurement. In
addition, real-time monitoring suggested that the neutron flux distribution and intensity at the region of interest
(ROI) may vary due to the reactor condition, patient motion and dislocation of the SOF detector.
Conclusion: Clinical measurements using the SOF detector to measure thermal neutron flux during BNCT
confirmed that SOF detectors are effective as a real-time thermal neutron monitor. To minimize the estimation error
due to the displacement of the SOF probe during treatment, a loop-type SOF probe was developed.
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Background
Boron neutron capture therapy (BNCT) is the combination
of external irradiation (thermal neutrons or epithermal
neutrons) and internal irradiation (α particle and lithium
nuclei). In other words, a boron 10B compound is select-
ively introduced into tumor cells and is externally irradiated
with thermal or epithermal neutrons. The thermal neutrons
interact with 10B in the tumor cells and result in high linear
energy transfer (LET) α and lithium 7Li particles through
boron neutron capture reaction 10B(n,α)7Li. The very short
range of α particles (~8 μm) and 7Li particles (~5 μm) helps
to destroy 10B loaded tumor cells at the cellular level with
minimum damage to neighboring 10B unloaded normal
cells. The first clinical trial of BNCT was carried out by Farr
et al. at Brookhaven National Laboratory (BNL) in 1951 but
the results were not satisfactory [1]. Later, Hatanaka et al.
performed clinical trials on 13 brain tumor patients at Hita-
chi Training Reactor (HTR) from 1968 to 1975. The en-
couraging outcomes stimulated interest in BNCT [2]. In
1987, Mishima et al. started a clinical trial of BNCT for ma-
lignant melanoma using Kyoto university reactor KUR [3].
In a clinical study carried out by Nakawaga and Hatanaka
on 149 patients treated with BNCT between August 1968
and April 1995 considered BNCT as an ideal treatment for
malignant brain tumors because of the quality of life after
treatment [4]. Currently, BNCT offers the most effective
treatment for primary and metastatic tumors, specifically
glioblastoma multiforme and malignant melanomas for
which effective therapy has not yet been developed [5].
However, the procedure for BNCT is one of the most com-
plex cancer treatment modalities and the effectiveness of
this therapy depends on the neutron and boron distribution
[6]. In clinical BNCT, the continuous monitoring of the
neutron flux distribution is necessary because the distribu-
tion and intensity may vary depending on the reactor con-
dition or the physical feature of the patients [7]. Their
accurate and real-time assessment during irradiation is also
essential for the quality assurance of the treatment.
Detectors that are used for thermal neutron monitor-
ing include 10BF3 or
3He gas counters, ionization cham-
bers, fission chambers and proton-recoil spectrometers
[8]. The gold wire or foil activation method is also used
for the same purpose. Gas-filled detectors and activation
spectrometry are considered as the primary tool for neu-
tron beam dosimetry and monitoring in BNCT. Gas
filled detectors are commonly used for phantom meas-
urement but for in-vivo measurement they are not fre-
quently used because of their large physical size and
high sensitivity to electric noise. Gold wire is the most
common method used to measure thermal neutron flu-
ence in-vivo dosimetry. Other radiation technologies
have also been developed for the same purpose, such as
scintillators, thermoluminescent dosimeters (TLD), gel
detectors and self-powered neutron detectors [9–12].
In most BNCT clinical cases, thermal neutron fluence
has been measured by means of the gold wire activation
method. However, the real-time measurement of thermal
neutron flux using this method is not possible since neu-
tron activation of the gold wire alone requires at least sev-
eral minutes. In our previous work, we developed a plastic
scintillator with optical fiber (SOF) for online thermal
neutron measurements in BNCT [9, 13]. Details of the
characteristics and properties of the SOF detector can be
found in our former study. Initially, we used a boron com-
pound as a neutron converter in the scintillator and two
clinical measurements were performed using a boron
loaded SOF detector. The output this detector showed
good agreement with gold wire measurements but the
measured value comprised of much electric noise and was
latter replaced by a LiF mixed scintillator.
In the present research, measurements were carried
out on a total of 16 patients using the SOF detector,
until the end of 2006 at Japan Atomic Energy Agency
(JAEA) / JRR4 and Kyoto University Research Reactor
Institute (KURRI). In the first two clinical cases boron
loaded scintillators were used, and in the remaining 14
cases LiF mixed scintillators were used. The main pur-
pose of this study was to demonstrate the feasibility of
the SOF detector as a real-time thermal neutron moni-
tor during BNCT treatment based on results of clinical
measurements. We also report in this paper about issues
we experienced in the use of SOF detectors in clinical
BNCT practice and their solutions.
Materials and methods
Measurement system
All measurement data presented in this paper were ob-
tained using the paired and single SOF detector systems.
The components of the paired system are similar to the
former SOF detector system described in our earlier work
[9]. Fig. 1 shows a schematic diagram of the paired SOF
detector system. The other components of the SOF de-
tector include optical fibers, photon counting units and
counters. The photon-counting unit (Hamamatsu H7155)
consists of a photo-multiplier tube, a pre-amplifier and a
discriminator. In this research, we used a BC490 plastic
scintillator manufactured by Bicron Ltd. The BC490 is
partially polymerized and hardened with a catalyst which
makes it possible to be tightly connected to the tip of a
plastic optical fiber (Mitsubishi Rayon MH4002, 1 mm-
diameter optical fiber with 2.2 mm-diameter polyethylene
shielding). A small amount of LiF powder (enriched 95 %
6Li) was mixed with one of the plastic scintillators. The re-
actions between 6Li nuclei and thermal neutrons emit
charged particles (alpha and triton), which produce scintil-
lation photons in the plastic scintillator.
The photon signals are relayed through the optical
fiber to the Photon Counting Unit and then converted
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into 30 ns-width TTL pulses. The pulse counts are sent
to a personal computer via a universal serial bus (USB)
connection. When using a plastic scintillator for count-
ing neutrons, the signals in the detector can be produced
by alpha particles, Li nuclei, recoil protons and gamma
rays. It is necessary to clearly differentiate the signals
produced by these particles in order to correctly esti-
mate thermal neutron flux. The signal from gamma rays
can be the main source of noise for SOF detector. Al-
though a plastic scintillator hardly causes photoelectric
effect, a signal from the Compton scatter of high-energy
gamma rays contributes significantly to the total signal
measured by the detector. This gamma ray contribution
can be minimized if a very small detector is used for
measurement. To account for the gamma ray and fast
neutron signals, scintillators without 6LiF were used,
which include only gamma ray and fast neutron signals.
The contributions from the gamma rays and fast neu-
trons can be delineated and corrected based on the dif-
ference between the signals obtained from the
scintillator without 6LiF and the signals from the scintil-
lator with 6LiF.
In a few cases, a single SOF detector has been adopted
to increase the number of monitoring points. A single
SOF detector has almost the same composition and
characteristics as the paired detector except for the
gamma-ray and fast-neutron signal correction. Since the
thermal neutron flux measured by the single SOF de-
tector was similar as that of the paired detector, the sin-
gle SOF was as effective as a relative neutron fluence
monitor. Furthermore, because the cross-section of 6Li
is almost proportional to that of 10B for neutron energy
range in reactor-based BNCT, the reaction rate of 6Li is
proportional to the 10B dose in the tumor.
SOF measurement in clinical use
Clinical trial measurements with the SOF detector
started in December 2002. By the end of 2006, we had
conducted a total of 16 clinical measurements. In clinical
measurements, the SOF detectors were placed at the
center of the region of interest (ROI) (detector 1), per-
ipheral of interest (detector 2) and in front of collimator
(detector 3) as shown in Fig. 2. These detectors were
used as a thermal neutron flux monitor at the ROI (de-
tector 1) and as a patient’s motion monitor (detector 2)
and reactor power fluctuation monitor (detector 3). In
all BNCT treatments, the gold wire activation method
was the primary method for estimating thermal neutron
flux. The SOF detectors were placed without disturbing
the gold wire measurement. Thermal neutron irradiation
was used for treating skin melanoma. For patients with
glioblastoma, parotid cancer and fibrosarcoma, epither-
mal neutrons beams were used. Here, a paired SOF
probe was mainly used for neutron fluence monitoring
while a single SOF probe was used for patient-motion
detection.
Calibration
In the present work, efficiency for each detector varied
due to non-identical sizes of the scintillator, transmission
USB
Driv er
Plastic scintillator
(w/ and w/o neutron
conv erter)
60 MHz
Counter
60 MHz
Counter
Ref lector
(BC620)
Photon Counting
Unit (H7155)
Photon Counting
Unit (H7155)
Paired optical f iber
(MH4002)
Fig. 1 Schematic diagram of the paired SOF detector system. The signal processing of the paired SOF detector is exactly the same as the single
SOF detector. The paired probe consists of a plastic scintillator with and without LiF or boron as a neutron converter
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loss of optical fiber, gain of photo-multiplier tubes and
slightly different discrimination level. Correction factors
for the measured counts by each detector were estab-
lished in order to account for the difference in the rela-
tive efficiencies of the detectors. The measured counts
for the scintillator with and without 6LiF were assumed
to be expressible in terms of Eqs. (1) and (2), respect-
ively as
Cþ ¼ Rnþ⋅Fn þ Rgþ⋅Fg þ Rfþ⋅Ff ð1Þ
C− ¼ Rg−⋅Fg þ Rf −⋅Ff ð2Þ
In Eq. (1), C+ represents the measured counts of the
scintillator with 6LiF. Fn, Fg, and Ff are the particle flu-
ence for neutrons, gamma rays and fast neutrons re-
spectively. Rn+, Rg+, and Rf+ are the detector response
factor for thermal neutrons, gamma rays and fast neu-
trons respectively. In Eq. (2), C−, Rg-, and Rf- are the
measured counts, response factor for gamma rays and
fast neutrons, respectively, for the scintillator without
6LiF.
C
0
þ ¼ Rgþ⋅F
0
g ð3Þ
C
0
− ¼ Rg−⋅F
0
g : ð4Þ
Here, C’+ and C’− are the measured gamma ray counts
for the detectors with and without the neutron con-
verter, respectively. The response factors Rg+ and Rg-
were obtained from the measured counts of both detec-
tors when only a gamma-ray field was used following
Eqs. (3) and (4). These correction factors were deter-
mined from measurements using an intense pure
gamma-ray source such as 137Cs.
The response ratio Rg+/Rg- can be expressed in terms of
C’+ and C’− from Eqs. (3) and (4). Since the detector re-
sponse depends only on the scintillator volume, the
response factors Rf+ and Rf- should be proportional to Rg+
and Rg-, respectively. We obtain C+ in the form of Eq. (5).
Cþ ¼ Rn⋅Fn þ Rgþ
Rg−⋅C− ¼ Rn⋅Fn þ C
0
þ
C
0
−
⋅C−
ð5Þ
The expression for the neutron flux Fn can then be de-
duced from Eq. (5) and is given by Eq. (6).
Fn ¼
Cþ−
C
0
þ
C
0
−
⋅C−
Rnþ
ð6Þ
Similarly, we can also calculate the uncertainties for
the thermal neutron flux, using the relative standard de-
viation given by,
σFn
Fn
¼
1ﬃﬃﬃﬃﬃ
Cþ
p
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ RgþRg−
 2
C−
Cþ
r
1− RgþRg−
C−
Cþ
ð7Þ
Expected fluence and estimation error
When the neutron fluence at any arbitrary time of ir-
radiation is known, we can calculate the neutron fluence
at the required time by using simple rules of mathemat-
ics. In our case, the first 15 min value of the neutron flu-
ence was obtained and referred as the “pull-out” value
FSOF, pull-out. On the basis of the pull-out value, we can
calculate the neutron fluence during the total irradiation
time Tirrad and referred as the Expected fluence FSOF,exp
given by
FSOF ; exp ¼ TirradTpull−out ⋅FSOF ;pull−out ð8Þ
The neutron fluence obtained from Eq. (8) is the calcu-
lated neutron fluence during the entire irradiation time.
The expected neutron fluence is a calculated mathematical
Detector 1
Detector 2
Gold wire 
Detector 3
Fig. 2 SOF detectors arrangement in clinical use during BNCT. The SOF detectors are placed at the center of ROI (detector 1), peripheral of
interest (detector 2) and in front of the collimator (detector 3) without disturbing the gold wires
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value which may differ from that of the observed neutron
fluence. During clinical trials, the neutron fluence measured
by the SOF detector may be slightly different from that the
expected value. This difference in the expected fluence FSO-
F,exp, and the observed fluence FSOF, Final, gives rise to an
error referred as the estimation error ESOF. The error was
obtained using the percent error formula given below.
ESOF ¼ FSOF ; Final−FSOF ; exp
FSOF ; exp
ð9Þ
Similarly, the estimation error for the gold wire EAU is
given by
EAu ¼ FAu; Final− FAu; exp
FAu; exp
ð10Þ
Here, the full irradiation time was determined from
constraints of skin dose or vascular dose and minimum
tumor dose. The “pull-out” and “final” values were based
on the SOF detector placed on the patient skin.
Results
Clinical measurements
Table 1 shows a summary of the BNCT clinical measure-
ments where the SOF detector was used. It is evident from
Table 1 that the neutron fluence estimated by the gold
wire activation method differs from that obtained with the
SOF detectors. The neutron fluence obtained by the SOF
detector was in better agreement with the expected flu-
ence than the gold wire activation. Thus, the estimation
errors for the SOF detector were found to be smaller in
most cases compared to the gold wire method. The esti-
mation error for the SOF detector and gold wire was cal-
culated using (9) and (10), respectively. The highest
estimation error for the SOF detector was observed in
cases 4 and 14 and the lowest occurred in cases 6 and 13.
The estimation errors were based on the neutron flux
monitor at the ROI. In case 10, irradiation was performed
during surgery (craniotomy) and the SOF detector was
placed on the edge of the collimator instead of the patient
skin. The estimation error in this case was based on the
neutron flux monitor at the ROI. Similarly, in case 12, the
SOF detector was put under the patient’s right ear tube.
Thus, in cases 10 and 12, the estimation error is not based
on the neutron flux monitor at the ROI.
A real-time monitoring by SOF detector in BNCT
treatment
The monitoring position of the SOF detector for cases 4,
6, 9 and 14 are shown in Fig. 3a,b,c and g, respectively.
Table 1 A summary of clinical trials in BNCT
No. Tumortype Reactor
(Mode)
Irrad.
time
[min.]
Probe
type
Fluence [n/cm2] Expected
fluence
[n/cm2]
Estimation error (%)
SOF detector Gold wire Gold SOF
Pull-out Final Pull-out Final
1 G KUR(E) 120 BP 1.01 × 1011 7.72 × 1011 1.12 × 1011 9.58 × 1011 8.93 × 1011 7.26 −4.46
2 G KUR(E) 60 BP 1.29 × 1011 5.02 × 1011 1.17 × 1011 4.90 × 1011 4.68 × 1011 4.62 −2.68
3 F KUR(E) 80 LS 2.18 × 1011 1.17 × 1012 2.09 × 1011 1.20 × 1012 1.11 × 1012 7.76 0.55
4 P KUR(E) 83 LS 1.39 × 1011 6.22 × 1011 1.14 × 1011 4.82 × 1011 6.30 × 1011 −23.46 −18.66
5 G KUR(E) 90 LS 1.18 × 1011 6.92 × 1011 2.03 × 1011 1.09 × 1012 1.22 × 1012 −10.22 −2.18
6 G KUR(E) 87 LS 1.24 × 1011 7.25 × 1011 1.36 × 1011 7.86 × 1011 1.63 × 1012 −0.35 0.47
7 G KUR(E) 90 LS 1.41 × 1011 8.27 × 1011 3.01 × 1011 1.93 × 1012 1.80 × 1012 6.89 −2.27
8 G KUR(T) 60 LP 1.55 × 1011 6.02 × 1011 3.17 × 1011 1.21 × 1012 1.27 × 1012 −4.26 −2.82
9 M KUR(T) 90 LP 7.86 × 1011 4.60 × 1012 9.27 × 1010 5.89 × 1011 5.56 × 1011 5.83 −2.46
10a G JRR4(E) 69 LP 2.64 × 1011 1.03 × 1012 3.05 × 1012 1.25 × 1013 1.41 × 1013 −11.10 −4.86
11 G JRR4(E) 34 LP 4.19 × 1011 8.62 × 1011 3.14 × 1012 7.03 × 1012 7.13 × 1012 −1.43 −0.67
12b G JRR4(E) 32 LP 1.31 × 1010 2.68 × 1010 3.05 × 1012 6.49 × 1012 6.52 × 1012 −0.38 −3.30
13c M JRR4(T) 75 LP 6.61 × 1011 3.00 × 1012 8.30 × 1011 4.59 × 1012 4.26 × 1012 7.83 −0.15
14 G KUR(E) 90 LP 2.08 × 1011 1.17 × 1012 3.11 × 1011 1.91 × 1012 1.87 × 1012 2.02 −6.28
15d P JRR4(E) 25 LL 4.43 × 1011 1.06 × 1012 2.91 × 1012 4.77 × 1012 4.85 × 1012 −1.61 0.65
16d G JRR4(E) 29 LL 5.76 × 1011 1.54 × 1012 2.93 × 1012 5.51 × 1012 5.67 × 1012 −2.84 −1.82
In Tumor Type column, G,P,M and F stand for Gliobrastoma, Parotid cancer, Melanoma and Fibro sarcoma, respectively
In Reactor (Mode) column, (E) and (T) stand for epi-thermal neutron and thermal neutron irradiation respectively
In the Probe Type column, BP, LS, LP and LL stand for paired boron-loaded, single lithium mixed, paired lithium mixed and loop-type lithium mixed, respectively
aIrradiation performed during craniotomy, SOF detector placed on the edge of the collimator instead of patient skin
bSOF detector placed under patient ear tube
cGold wire placed on the patient skin (Except case 14 all cases in JRR, gold wire placed inside the port)
dFirst 10 min used for calculating the expected fluence
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Similarly, Fig. 3d,e,f and h show the SOF detector work-
ing effectively as a real-time thermal neutron monitor in
clinical BNCT for cases 4,6,9 and 14, respectively. From
the real-time monitor we noted that any changes in the
neutron flux monitor of detector 2 and 3 affected the
neutron flux measured by detector 1.
According to Table 1, in case 4, it was realized that the
total amount of irradiation was 18.66 % lower than ex-
pected. The decline in the thermal neutron flux was ob-
served in real-time as shown in Fig. 3d. Both the output of
the monitor at the center of the ROI and the monitor near
the edge of the ROI declined continuously. However, the
same drastic change in the thermal flux was not observed
by another SOF monitor placed in front of the collimator.
This was the highest decline in the neutron flux in the en-
tire clinical measurements. The continuous decline in the
neutron flux shown by detector 1 was most probably due
to the change in the position of the patient during
irradiation.
Errors seem to decrease in cases 6 and 9. In case 6
(Fig. 3e), the neutron flux monitor in front of the col-
limator remained fairly constant. The estimation error
0.47 % in this case was most probably due to the
slight change in the flux at the peripheral of the ROI.
On the other hand, in case 9 (Fig. 3f ) both the moni-
tor in front of the collimator and near the periphery
of interest showed decline in the thermal neutron
flux. Therefore, in this case the neutron flux at the
ROI was affected by the patient motion and reactor
power fluctuation. In all above cases, the dislocation
of SOF detector from the original position was not
observed.
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Fig. 3 The monitoring position of the SOF detectors during BNCT at case (a) 4 (b) 6 (c) 9 (g) 14 (SOF probe before and after irradiation). d, e, f
and h show the real-time measurements of the thermal neutron flux by the SOF detector during BNCT for cases 4, 6, 9 and 14, respectively
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Figure 3g shows the location of the SOF detector
probe before and after irradiation for case 14. As shown
in Fig. 3g, the probe was inside a red circle before irradi-
ation; however, after irradiation the probe was located
outside of the red circle. The decline in neutron flux
near the edge of the collimator was observed after
3,600 s of irradiation. Similarly, the real-time monitor at
ROI showed decline in the flux after 4,800 s of irradi-
ation. In this case, the dislocation of the probe from the
original position affected the SOF measurements.
Measurement uncertainty of gold wire and SOF detector
The measurement uncertainty for the SOF detector can
be deduced from Eqs. (1), (2), (6) and (7). From Eq. (7),
the uncertainties for thermal neutron flux at 108 n/cm2/s
and 109 n/cm2/s are 0.53 % and 0.17 %, respectively. Here,
we used parameters for response ratio Rg+/Rg- = 1,
gamma-ray contribution ratio C−/C+ = 0.1 and the re-
sponse factor Rn+ = 2,072 n/cm
2/counts from our previous
work [6]. The estimated uncertainty does not contain cali-
bration uncertainty for absolute measurement. Similarly,
measurement uncertainties for the gold wire activation
method at KURRI and JRR4 were estimated as 5.82 % ±
1.73 % and 1.32 % ± 0.40 %, respectively for estimating
thermal neutron flux at the beginning. The gold wire mea-
surements at KURRI were performed on the patient skin
where the average thermal neutron flux was 3.21 × 108 n/
cm2/s. At JRR4, gold wire measurements were performed
inside the beam port where the average thermal neutron
flux was 3.83 × 109 n/cm2/s. This is 12 times higher than
at KURRI. The measurement acquisition times for the ac-
tivation were 60 s at KURRI and 103.8 s (30–200 s) at
JRR4.
Discussion
From the result section, we observed that the real-time
monitoring of the thermal neutron distribution was pos-
sible with the help of the SOF detector. The gold wire
method cannot be used for the same purpose because it
provides only retrospective and integrated information
on the neutron flux distribution. The difference in the
estimated neutron fluence by the gold wire method and
SOF detector was likely due to the difference in the loca-
tion of the detector and the gold wire. The gold wire
was placed on the patient skin at KURRI and inside the
beam port at JRR4. Even at the skin surface, the position
of the SOF detector did not align exactly with the pos-
ition of gold wire 1 (pulled out after 15 min) or gold
wire 2 (irradiated to the end of the treatment).
Generally, the gold wire is pulled out after the first
15 min of irradiation. The location of the SOF detector
and the gold wire is also different (in case of JRR 4, gold
wire was placed inside the port) and even on the patient
skin the position of the SOF detector did not align
exactly with the position of gold wire 1. This makes dir-
ect comparison between the SOF detector and gold wire
measurement difficult. Similarly, TLD is only useful for
gamma dosimetry. Thus, in the current research the
neutron flux measured by the SOF detector was com-
pared with the expected fluence because it was similar
to that of the treatment planning system. However, the
test level of the SOF detector can be further improved
by comparing the results with simulation techniques
which are capable of modeling complex geometries.
Issues and solutions in the clinical use of the scintillator
with optical fiber (SOF) detector
We observed that the measurement uncertainty of the
SOF detector was quite small and its contribution in
SOF detector estimation error was not of much signifi-
cance. The main source of error in SOF detector meas-
urement at the ROI is due to the variation in the reactor
condition, patient motion and dislocation of the SOF de-
tector from the original position. Thus, the measured
data should be carefully reviewed.
It was shown that change in the positioning of the pa-
tient affected the SOF measurements. Thus, for calculat-
ing accurate tumor dose the patient positioning should
always be monitored continuously. Figure 4, shows the
distribution of thermal neutron flux for case 1 measured
by the gold wire. Here, the gradient of thermal neutron
flux differs according to the measured position. Gener-
ally, the gradient of thermal neutron flux near the colli-
mator edge is relatively larger than at the center.
Therefore, the placement of the SOF detector near the
collimator edge is more effective for monitoring patient
movement during irradiation. Even though the patient
has moved during irradiation, skin dose at the SOF de-
tector position can be assessed in real-time. Similarly,
the fluctuation of the reactor power directly affects the
tumor dose and skin dose. The fluctuation of the reactor
power can be monitored stably at the site where meas-
urement is not affected by patient motion such as in
front of the collimator or inside the beam port.
The displacement of the SOF detector probe from the
patient skin happened during treatment in case 14 as
shown in Fig. 3g. Due to the displacement of the probe,
it was impossible to estimate the measured position and
thus the measured value will be of less importance. A
strong adhesive tape could not be used during treatment
since it was harsh on the patient’s skin. The displace-
ment of the probe also occurred as the adhesive tape
was weakened by patient’s sweat during treatment. Close
adhesion to the skin is especially difficult for a patient
who had a craniotomy because of difficulty of shaving
around the irradiated area. The neutron flux decreases
as the distance from the central beam axis increases, as
shown in Fig. 4. Thus, in case 14, the SOF detector
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displaced away from the beam axis (Fig. 3g) during ir-
radiation and a small decline in the neutron flux was re-
corded by the real-time monitor (Fig. 3h) of detector 1
and 2 around 4,800 and 3,600 s, respectively. This af-
fected the accuracy of the detected neutron flux and
consequently affected the SOF measurement.
To overcome the displacement issue, we developed a
loop type probe as shown in the Fig. 5. Originally, the
SOF probe consisted of two identical optical fibers with
scintillators. The two scintillators were constructed such
that they face each other. Since the loop-type probe can
be fixed from two directions, it is expected that a meas-
urement error due to the probe detachment during
treatment would be minimized. The loop type probe was
adapted in cases 15 and 16. Figure 5, shows that the
SOF probe remained in its original position during the
entire irradiation and also the significant change in the
neutron flux was not observed in the real-time monitor.
SOF detector at low neutron field
The monitoring position of the SOF detector at the
pacemaker is shown in Fig. 6a. A 5-mm-thick thermal
neutron shield sheet containing B4C was used to cover
the pacemaker. This helps to reduce the thermal neu-
tron flux in the pacemaker region. The thermal neutron
flux measured at the pacemaker position was fluctuating
between 104 and 105 n/cm2/s, as shown in Fig. 6b, where
the graph was plotted as a 30-seconds moving average.
The fluctuation in the measurement was larger com-
pared to the flux at 108 n/cm2/s. The total thermal neu-
tron fluence on the pacemaker position was obtained as
4.74 × 108 n/cm2. This confirms that the SOF detector is
able to measure thermal neutron flux as low as 105n/
cm2/s. The gold wire may take a few days to measure
the same order of thermal neutron flux.
Soft error rate (SER) may be induced when a semicon-
ductor device on a pacemaker is subjected to irradiation..
The maximum tolerable cumulative radiation dose for safe
operation of a pacemaker depends highly on the pace-
maker type, model and the dose rate [14]. SER of a semi-
conductor device due to thermal neutron flux of 105 n/
cm2/s from a nuclear reactor is about 5 times higher than
environmental level thermal neutron flux [15]. Since, the
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SER of the environmental thermal neutron flux is very
low, the potential effect on the pacemaker by the thermal
neutron field may have been negligible in this case. How-
ever, the current manuscript does not aim to determine
the safe irradiation limit of pacemakers during BNCT
treatment.
Comparison between boron loaded and LiF mixed SOF
detector
Figure 7a,b show the measurement results for the
paired boron-loaded probe (Case 1) and the paired
LiF-mixed probe (Case 10), respectively. The fluctua-
tions in the thermal neutron flux measured by the
boron-loaded and the LiF-mixed probes were 2.85 %
at 1.1 × 108 n/cm2/s (2.94 × 104 cps) and 0.71 % at
2.5 × 108 n/cm2/s (1.12 × 105 cps), respectively. If the
LiF-mixed probe was used at 1.1 × 108 n/cm2/s, the
expected fluctuation will be 1.07 %. This indicates
that the measurement using LiF-mixed probe was
more stable than the boron-loaded probe. In case 10,
the estimation error based on reactor monitor was
−1.59 % indicating that the SOF measurement was
in good agreement with the reactor monitor. Cases 1
and 10 showed that the LiF-mixed probe measure-
ments were less fluctuating than the boron-loaded
probe. This was due to the fact that when LiF
(enriched 95 % 6Li) interacts with a neutron it emits
a large Q-value and two energetic particles: a triton
particle (2.05 MeV) and an alpha particle
(2.73 MeV). The light yielded from triton is nearly a
factor of 10 times higher than that of the 1.5 MeV
alpha particle from neutron capture on 10B[16].
Thus, we used the boron-loaded probe only in the
first 2 cases and in the remaining 14 cases the LiF
mixed probe was used.
Conclusion
Clinical measurements using the SOF detector to meas-
ure thermal neutron flux during BNCT treatment con-
firmed that SOF detectors were effective as a real-time
thermal neutron monitor. The real-time monitoring of
the thermal neutron by SOF detector suggests that the
neutron flux distribution and intensity at the ROI vary
due to the reactor condition, patient motion and disloca-
tion of the SOF detector. To minimize the detector dis-
placement problem, a loop-type probe was developed.
The authors believe the presented work will contribute
towards the field of on-line neutron monitoring in clin-
ical BNCT irradiation.
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